期刊
NATURE CHEMICAL BIOLOGY
卷 18, 期 11, 页码 1236-+出版社
NATURE PORTFOLIO
DOI: 10.1038/s41589-022-01102-7
关键词
-
资金
- National Institutes of Health [P01AI118687, R01CA077373, R35263778]
- DOE Office of Science by Brookhaven National Laboratory [DE-SC0012704]
- National Institute of General Medical Sciences [P30GM133893]
- DOE Office of Biological and Environmental Research [KP1607011]
The antimicrobial resistance crisis necessitates the development of new antibiotics. In this study, a novel antimicrobial compound called evybactin was discovered from Photorhabdus noenieputensis, which exhibited potent and selective antibacterial activity against Mycobacterium tuberculosis. Evybactin was found to target DNA gyrase and utilized a promiscuous transporter, BacA, to enter the bacterial cell.
The antimicrobial resistance crisis requires the introduction of novel antibiotics. The use of conventional broad-spectrum compounds selects for resistance in off-target pathogens and harms the microbiome. This is especially true for Mycobacterium tuberculosis, where treatment requires a 6-month course of antibiotics. Here we show that a novel antimicrobial from Photorhabdus noenieputensis, which we named evybactin, is a potent and selective antibiotic acting against M. tuberculosis. Evybactin targets DNA gyrase and binds to a site overlapping with synthetic thiophene poisons. Given the conserved nature of DNA gyrase, the observed selectivity against M. tuberculosis is puzzling. We found that evybactin is smuggled into the cell by a promiscuous transporter of hydrophilic compounds, BacA. Evybactin is the first, but likely not the only, antimicrobial compound found to employ this unusual mechanism of selectivity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据